Navigation Links
IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
Date:6/7/2012

NEW YORK, June 7, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC) announced today that Dr. Arnold I. Caplan has joined its Scientific Advisory Board.  Dr. Steven Victor, CEO of IntelliCell, stated "Dr. Caplan's expertise in regenerative medicine is acknowledged in our entire industry and we are very pleased to have him assist our company as it moves forward.  Dr. Caplan's unique experience in our industry has helped emerging companies take many products from the laboratory and into successful commercialization and our team is looking forward to learning and working with him."  Professor Caplan has lectured and published extensively in the field of regenerative medicine including stem cells, development and bone biology and is recognized as one of the world's foremost authorities on cellular therapies.  Dr. Caplan stated, "The IntelliCell product is a platform for cellular delivery to promote and support the natural regeneration of focal injuries that may occur almost anywhere in the body."  

About IntelliCell BioSciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous vascular cells (SVC's) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, universities, and international business entities.

About Arnold I. Caplan Ph. D.
Dr. Caplan is a Professor of Biology & General Medical Sciences and Director of the Skeletal Research Center at Case Western Reserve University in Cleveland, Ohio.  Professor Caplan has published over 300 manuscripts and articles in peer reviewed journals.  Dr. Caplan ha
'/>"/>

SOURCE IntelliCell BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
2. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
3. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
4. ERT Announces Clearance from German Federal Cartel Office
5. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
6. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
7. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
8. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
9. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
10. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
11. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015   Regulus ... biopharmaceutical company leading the discovery and development of ... Kleanthis G. Xanthopoulos , Ph.D. has resigned as ... member of Regulus, Board of Directors, effective today, ...  Paul Grint, M.D., who previously served as Chief ...
(Date:6/1/2015)... The nuclear imaging market is estimated to grow to ... Nuclear medicine is the use of radioisotopes for the ... imaging used commonly are PET and SPECT. Till recently, ... applications like nuclear cardiology procedures. However, the trend is ... molybdenum-99 isotope which is in turn will lead to ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3
... Conference on Avian,Influenza at France's Pasteur Institute, PARIS, ... of,Novavax Inc.'s pandemic influenza vaccine provided protection,against a ... data presented here today at the Second International,Conference ... show that two 0.6 microgram doses of Novavax's,virus-like ...
... of Rare but Devastating,Condition , LONDON, June 1, ... of Leicester and have today (Friday June 1),announced ... rare but,devastating medical condition that can affect children ... clinicians and scientists from the two,universities have already ...
Cached Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity ... summer fashion cocktail dresses. The company carries more than ... be suitable for a wide variety of summer events ... and make high quality trendy special occasion dresses ... quality satin, chiffon and cotton. Their products feature a ...
(Date:6/2/2015)... 2015 Consumer Reports, the world’s ... announced its commitment to help wipe out antibiotic-resistant ... of antibiotics sicken about 2.25 million Americans each ... for Disease Control and Prevention. , The initiative ... Marta Tellado participating in the White House Forum ...
(Date:6/2/2015)... 2015 Amercanex, the American Cannabis ... to become Amercanex’s new Chief Technology Officer. Amercanex ... which cultivators, wholesale distributors and retail vendors can ... fully transparent intra-state market. , Jim Miller is ... technology space, helping innovative technology companies deliver on ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help from ... to support ovarian cancer research conducted by Cheng Wang, Ph.D. ... Colleen’s Dream Foundation Board of Directors. , Cundiff says the ... Colleen’s Dream Foundation and they couldn’t have picked a better ... a rising star in the ovarian cancer world,” says Cundiff. ...
(Date:6/2/2015)... 2015 Each year, Cosmetic Executive Women ... Awards. This year, the organization’s members – 8,000 industry ... the QVC® Beauty Quest Award at the 2015 Beauty ... (ME) Technology and 2-in-1 approach to skincare differentiated it ... brand’s loyal consumer and professional fan bases, QVC has ...
Breaking Medicine News(10 mins):Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:, ... conjunction with the 2009 ... corporate update will be presented by Stanley T. Crooke, M.D., ... Executive Officer of Isis., When: Tuesday, June 2, 2009, ...
... VIDEO ALERT: Additional audio and video resources, including excerpts ... the research, are available on the Mayo Clinic ... Mayo Clinic compared two popular television shows, CSI and ... clear differences between media portrayals of violent deaths versus ...
... Health Care CostsHARRISBURG, Pa., May 19 A budget ... or eliminate vital access to health care and services ... Everette James warned today."In today,s economic climate, access to ... Pennsylvanians. The Department of Health,s programs to expand access ...
... May 19 Boston Scientific Corporation (NYSE: BSX ... rating outlook to positive from stable, while affirming the Company,s ... reflects:, , ... its drug-eluting stent (DES) business and returning its cardiac rhythm ...
... Study Highlights the Clinical Success of Dental Implants ... 19 BioHorizons, a leader in the dental ... three-year prospective, controlled, multi-center study of implants with ... observed for Laser-Lok in vitro and ...
... in the womb , , TUESDAY, May 19 (HealthDay News) ... to become a regular smoker as a teen and ... University of Arizona researchers. , "Somehow smoke is changing ... Grad, an associate professor of clinical pediatrics at the ...
Cached Medicine News:Health News:Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders 2Health News:CSI: Mayo Clinic Researchers Find Television Shows Inaccurately Portray Violent Crime 2Health News:Senate's Proposed Budget Threatens the Health of Millions of Pennsylvanians 2Health News:Fitch Raises Boston Scientific's Rating Outlook to Positive 2Health News:Fitch Raises Boston Scientific's Rating Outlook to Positive 3Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 2Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 3Health News:Kids More Apt to Smoke If Mom Did While Pregnant 2Health News:Kids More Apt to Smoke If Mom Did While Pregnant 3
... C spins up to 25,000 x g for quick ... and ease of use. The Model 5417 C is ... a cold room and can accommodate a variety of ... , Spin up to 16,400 rpm; 25,000 x ...
... laboratory floor model centrifuge meets UL and ... suitable for use in Class 1, Group ... gasoline, petroleum, naphtha, benzol, lacquer, solvent vapors ... is so strict that the EXD design ...
... Hybridization Oven/Shaker rigidly controls the temperature ... of hybridization and washing steps. This ... of nucleic acids and proteins immobilized ... with radioactive and nonradioactive labeling systems ...
... Oven with circular clear acrylic chamber for ... HybriCycler Oven features microprocessor operation for precise ... the unit., Carousel rotates at 11 ... ,easily removable , Bottle Capacity - ...
Medicine Products: